Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The rise in popularity of anti-obesity medications (AOMs), such as popular brand names Ozempic and Wegovy could see a shift ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

The skyrocketing popularity of weight-loss drugs is fast becoming a state budgetary concern. Policymakers must choose between ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A new study from the Department of Veteran Affairs, published in Nature Medicine, found that GLP-1 weight loss drugs including Mounjaro, Ozempic, Wegovy and Zepbound, may offer benefits beyond weight ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...